J. Attali

发表

Impairment of coronary microvascular dilation in response to cold pressor--induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging.

A. Nitenberg, P. Valensi, S. Ledoux, 2001, Diabetes.

Microalbuminuria in obese patients with or without hypertension.

P. Valensi, M. Busby, M. Assayag, 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Impairment of skin vasoconstrictive response to sympathetic activation in obese patients: influence of rheological disorders.

P. Valensi, J. Attali, J. Pariés, 2000, Metabolism: clinical and experimental.

Lower-limb vascularization in diabetic patients. Assessment by thallium-201 scanning coupled with exercise myocardial scintigraphy.

P. Valensi, E. Cosson, F. Paycha, 2001, Diabetes care.

Determinants of echocardiographically measured left ventricular mass in diabetic patients with or without silent myocardial ischaemia.

A. Nitenberg, P. Valensi, M. Leutenegger, 1999, Diabetes & metabolism.

Phenformin-induced Lactic Acidosis in Diabetic Patients

F. Lemaire, R. Assan, J. Attali, 1975, Diabetes.

Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients.

A. Nitenberg, P. Valensi, M. Leutenegger, 1997, Diabetes & metabolism.

Tenth Annual Meeting of the European Association for the Study of Diabetes

A. J. Honour, W. A. Müller, P. Blackshear, 1974, Diabetologia.

Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors.

A. Nitenberg, P. Valensi, S. Ledoux, 1998, Circulation.

Impaired coronary endothelium-dependent vasodilation is associated with microalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries.

A. Nitenberg, P. Valensi, E. Cosson, 2006, Diabetes care.

Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: a 10 year follow-up study.

D. Chemla, A. Nitenberg, P. Valensi, 2005, Atherosclerosis.

Long-Term Discontinuation of Insulin Treatment in a Type 1 Diabetic Patient

P. Valensi, E. Cosson, F. Paycha, 2022 .

Glucagon Secretion Induced by Natural and Artificial Amino Acids in the Perfused Rat Pancreas

J. Girard, J. Boillot, R. Assan, 1977, Diabetes.

Prognosis for coronary stenoses in patients with diabetes and silent myocardial ischemia.

P. Valensi, E. Cosson, F. Paycha, 2003, Diabetes care.

Elevated Concentrations of Soluble E-Selectin and Vascular Cell Adhesion Molecule-1 in NIDDM: Effect of intensive insulin treatment

P. Valensi, L. Gattegno, J. Attali, 1998, Diabetes Care.

CSII in type 2 diabetic patients

J. Attali, 2006 .

Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes.

P. Valensi, E. Cosson, L. Carbillon, 2006, Diabetes & metabolism.

TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome

P. Valensi, G. Perret, J. Attali, 1996, Journal of endocrinological investigation.

Effect of insulin concentration on bioavailability during nasal spray administration.

P. Valensi, G. Perret, P. Zirinis, 1996, Pathologie-biologie.

Short-Term in Vitro Stimulatory Effect of Glucagon on T4 Secretion in Rat and Human Thyroid

P. Valensi, D. Darnis, J. Attali, 1986 .

Diphasic glucagon release induced by arginine in the perfused rat pancreas.

J. Boillot, R. Assan, J. Attali, 1972, Nature: New biology.

Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function

A. Nitenberg, P. Valensi, E. Aptecar, 1993, Diabetes.

Increased capillary permeability to albumin and diabetic neuropathy.

P. Valensi, M. Attalah, J. Attali, 1991, Diabetes research and clinical practice.

Endocrine investigations in two cases of feminizing Leydig cell tumour.

P. Valensi, J. Amouroux, C. Coussieu, 1987, Acta endocrinologica.

Thyroid stimulating antibodies in sarcoidosis.

P. Valensi, D. Valeyre, J. Battesti, 1994, Pathologie-biologie.

Leydig cell tumor estrogen secretion: Suppression by a gonadotropin releasing hormone agonist

P. Valensi, C. Coussieu, J. Attali, 1991, Journal of endocrinological investigation.

Feminizing Leydig cell tumor: endocrine and incubation studies

P. Valensi, J. Amouroux, C. Coussieu, 1987, Journal of endocrinological investigation.

Effect of nifedipine and nitrendipine on insulin release in non-diabetic obese patients: a double-blind, placebo-controlled study.

P. Valensi, B. Uzzan, R. Vassy, 1991, Methods and findings in experimental and clinical pharmacology.

Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia.

P. Valensi, E. Cosson, M. Leutenegger, 2001, Diabetes care.

Fas/Fas-Ligand pathway is impaired in patients with type 2 diabetes. Influence of hypertension and insulin resistance.

P. Valensi, E. Cosson, G. Feldmann, 2005, Diabetes & metabolism.

Detection of thyroid-stimulating antibodies in thyroid diseases, employing rat thyroid fragment perifusion

P. Valensi, D. Darnis, J. Attali, 1987, Journal of endocrinological investigation.

Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.

E. Cosson, P. Schaepelynck-Belicar, J. Attali, 2009, Diabetes & metabolism.

Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events?

P. Valensi, E. Cosson, F. Paycha, 2003, Diabetes & metabolism.

Influence of nutrients on cardiac autonomic function in nondiabetic overweight subjects.

P. Valensi, J. Attali, J. Pariés, 2005, Metabolism: clinical and experimental.

Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors.

A. Nitenberg, P. Valensi, E. Cosson, 2004, Diabetes care.

Cardiac autonomic function in obese patients.

P. Valensi, J. Attali, J. Pariés, 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study.

B. Estour, G. Vanzetto, P. Valensi, 2005, Diabetes care.

Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?

P. Valensi, E. Cosson, S. Cattan, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Ambiguous effects of colchicine and vincristine upon A2-cell response to arginine

J. Girard, J. Boillot, R. Assan, 1978, Diabetologia.

Aortic stiffness and pulse pressure amplification in Wistar-Kyoto and spontaneously hypertensive rats.

D. Laude, M. Safar, P. Valensi, 2007, American journal of physiology. Heart and circulatory physiology.

Asymptomatic diabetic cardiomyopathy: a noninvasive study.

J. Lanfranchi, P. Valensi, J. Attali, 1988, Diabetes research and clinical practice.

Effects of nifedipine and nitrendipine on insulin secretion in obese patients.

P. Valensi, B. Uzzan, G. Perret, 1991, Journal of cardiovascular pharmacology.